The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Biliary and Pancreatic Stents Market Research Report 2024

Global Biliary and Pancreatic Stents Market Research Report 2024

Publishing Date : Jun, 2023

License Type :
 

Report Code : 1738746

No of Pages : 92

Synopsis
Biliary and pancreatic stents are medical devices used to treat blockages in the bile ducts or pancreatic ducts. These devices are usually made of metal or plastic and are inserted into the ducts to help keep them open and allow bile or pancreatic juice to flow freely.Biliary stents are used to treat blockages in the bile ducts, which can be caused by a variety of conditions such as gallstones, tumors, or inflammation. They can be placed either temporarily or permanently depending on the cause of the blockage.

Global Biliary and Pancreatic Stents market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Biliary and Pancreatic Stents market research.

Key manufacturers engaged in the Biliary and Pancreatic Stents industry include Boston Scientific Corporation, Merit Medical Systems, Inc., Cook Group Incorporated, Olympus Corporation, ENDO-FLEX GmbH, Diagmed Healthcare Ltd., Q3 Medical Group, Hobbs Medical and ACE Medical, etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2022.

When refers to consumption region, % volume of Biliary and Pancreatic Stents were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Biliary and Pancreatic Stents market and estimated to attract more attentions from industry insiders and investors.

Report Scope

This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Biliary and Pancreatic Stents market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.

By Company

  • Boston Scientific Corporation
  • Merit Medical Systems, Inc.
  • Cook Group Incorporated
  • Olympus Corporation
  • ENDO-FLEX GmbH
  • Diagmed Healthcare Ltd.
  • Q3 Medical Group
  • Hobbs Medical
  • ACE Medical
  • Neuromedex

Segment by Type

  • Biodegradable Material
  • Polymer Material
  • Metal Material
  • Others

Segment by Application

  • Hospitals
  • Clinics
  • Others

Consumption by Region

  • North America (United States, Canada)
  • Europe (Germany, France, U.K., Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia)
  • Latin America (Mexico, Brazil, Argentina)
  • Middle East & Africa (Turkey, Saudi Arabia, UAE)

The Biliary and Pancreatic Stents report covers below items:

Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source

Index

1 Biliary and Pancreatic Stents Market Overview
1.1 Product Overview and Scope of Biliary and Pancreatic Stents
1.2 Biliary and Pancreatic Stents Segment by Type
1.2.1 Global Biliary and Pancreatic Stents Market Value Comparison by Type (2023-2029)
1.2.2 Biodegradable Material
1.2.3 Polymer Material
1.2.4 Metal Material
1.2.5 Others
1.3 Biliary and Pancreatic Stents Segment by Application
1.3.1 Global Biliary and Pancreatic Stents Market Value by Application: (2023-2029)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Global Biliary and Pancreatic Stents Market Size Estimates and Forecasts
1.4.1 Global Biliary and Pancreatic Stents Revenue 2018-2029
1.4.2 Global Biliary and Pancreatic Stents Sales 2018-2029
1.4.3 Global Biliary and Pancreatic Stents Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Biliary and Pancreatic Stents Market Competition by Manufacturers
2.1 Global Biliary and Pancreatic Stents Sales Market Share by Manufacturers (2018-2023)
2.2 Global Biliary and Pancreatic Stents Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Biliary and Pancreatic Stents Average Price by Manufacturers (2018-2023)
2.4 Global Biliary and Pancreatic Stents Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Biliary and Pancreatic Stents, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Biliary and Pancreatic Stents, Product Type & Application
2.7 Biliary and Pancreatic Stents Market Competitive Situation and Trends
2.7.1 Biliary and Pancreatic Stents Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Biliary and Pancreatic Stents Players Market Share by Revenue
2.7.3 Global Biliary and Pancreatic Stents Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Biliary and Pancreatic Stents Retrospective Market Scenario by Region
3.1 Global Biliary and Pancreatic Stents Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Biliary and Pancreatic Stents Global Biliary and Pancreatic Stents Sales by Region: 2018-2029
3.2.1 Global Biliary and Pancreatic Stents Sales by Region: 2018-2023
3.2.2 Global Biliary and Pancreatic Stents Sales by Region: 2024-2029
3.3 Global Biliary and Pancreatic Stents Global Biliary and Pancreatic Stents Revenue by Region: 2018-2029
3.3.1 Global Biliary and Pancreatic Stents Revenue by Region: 2018-2023
3.3.2 Global Biliary and Pancreatic Stents Revenue by Region: 2024-2029
3.4 North America Biliary and Pancreatic Stents Market Facts & Figures by Country
3.4.1 North America Biliary and Pancreatic Stents Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Biliary and Pancreatic Stents Sales by Country (2018-2029)
3.4.3 North America Biliary and Pancreatic Stents Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Biliary and Pancreatic Stents Market Facts & Figures by Country
3.5.1 Europe Biliary and Pancreatic Stents Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Biliary and Pancreatic Stents Sales by Country (2018-2029)
3.5.3 Europe Biliary and Pancreatic Stents Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Biliary and Pancreatic Stents Market Facts & Figures by Country
3.6.1 Asia Pacific Biliary and Pancreatic Stents Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Biliary and Pancreatic Stents Sales by Country (2018-2029)
3.6.3 Asia Pacific Biliary and Pancreatic Stents Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Biliary and Pancreatic Stents Market Facts & Figures by Country
3.7.1 Latin America Biliary and Pancreatic Stents Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Biliary and Pancreatic Stents Sales by Country (2018-2029)
3.7.3 Latin America Biliary and Pancreatic Stents Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Biliary and Pancreatic Stents Market Facts & Figures by Country
3.8.1 Middle East and Africa Biliary and Pancreatic Stents Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Biliary and Pancreatic Stents Sales by Country (2018-2029)
3.8.3 Middle East and Africa Biliary and Pancreatic Stents Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Biliary and Pancreatic Stents Sales by Type (2018-2029)
4.1.1 Global Biliary and Pancreatic Stents Sales by Type (2018-2023)
4.1.2 Global Biliary and Pancreatic Stents Sales by Type (2024-2029)
4.1.3 Global Biliary and Pancreatic Stents Sales Market Share by Type (2018-2029)
4.2 Global Biliary and Pancreatic Stents Revenue by Type (2018-2029)
4.2.1 Global Biliary and Pancreatic Stents Revenue by Type (2018-2023)
4.2.2 Global Biliary and Pancreatic Stents Revenue by Type (2024-2029)
4.2.3 Global Biliary and Pancreatic Stents Revenue Market Share by Type (2018-2029)
4.3 Global Biliary and Pancreatic Stents Price by Type (2018-2029)
5 Segment by Application
5.1 Global Biliary and Pancreatic Stents Sales by Application (2018-2029)
5.1.1 Global Biliary and Pancreatic Stents Sales by Application (2018-2023)
5.1.2 Global Biliary and Pancreatic Stents Sales by Application (2024-2029)
5.1.3 Global Biliary and Pancreatic Stents Sales Market Share by Application (2018-2029)
5.2 Global Biliary and Pancreatic Stents Revenue by Application (2018-2029)
5.2.1 Global Biliary and Pancreatic Stents Revenue by Application (2018-2023)
5.2.2 Global Biliary and Pancreatic Stents Revenue by Application (2024-2029)
5.2.3 Global Biliary and Pancreatic Stents Revenue Market Share by Application (2018-2029)
5.3 Global Biliary and Pancreatic Stents Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Boston Scientific Corporation
6.1.1 Boston Scientific Corporation Corporation Information
6.1.2 Boston Scientific Corporation Description and Business Overview
6.1.3 Boston Scientific Corporation Biliary and Pancreatic Stents Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Boston Scientific Corporation Biliary and Pancreatic Stents Product Portfolio
6.1.5 Boston Scientific Corporation Recent Developments/Updates
6.2 Merit Medical Systems, Inc.
6.2.1 Merit Medical Systems, Inc. Corporation Information
6.2.2 Merit Medical Systems, Inc. Description and Business Overview
6.2.3 Merit Medical Systems, Inc. Biliary and Pancreatic Stents Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Merit Medical Systems, Inc. Biliary and Pancreatic Stents Product Portfolio
6.2.5 Merit Medical Systems, Inc. Recent Developments/Updates
6.3 Cook Group Incorporated
6.3.1 Cook Group Incorporated Corporation Information
6.3.2 Cook Group Incorporated Description and Business Overview
6.3.3 Cook Group Incorporated Biliary and Pancreatic Stents Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Cook Group Incorporated Biliary and Pancreatic Stents Product Portfolio
6.3.5 Cook Group Incorporated Recent Developments/Updates
6.4 Olympus Corporation
6.4.1 Olympus Corporation Corporation Information
6.4.2 Olympus Corporation Description and Business Overview
6.4.3 Olympus Corporation Biliary and Pancreatic Stents Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Olympus Corporation Biliary and Pancreatic Stents Product Portfolio
6.4.5 Olympus Corporation Recent Developments/Updates
6.5 ENDO-FLEX GmbH
6.5.1 ENDO-FLEX GmbH Corporation Information
6.5.2 ENDO-FLEX GmbH Description and Business Overview
6.5.3 ENDO-FLEX GmbH Biliary and Pancreatic Stents Sales, Revenue and Gross Margin (2018-2023)
6.5.4 ENDO-FLEX GmbH Biliary and Pancreatic Stents Product Portfolio
6.5.5 ENDO-FLEX GmbH Recent Developments/Updates
6.6 Diagmed Healthcare Ltd.
6.6.1 Diagmed Healthcare Ltd. Corporation Information
6.6.2 Diagmed Healthcare Ltd. Description and Business Overview
6.6.3 Diagmed Healthcare Ltd. Biliary and Pancreatic Stents Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Diagmed Healthcare Ltd. Biliary and Pancreatic Stents Product Portfolio
6.6.5 Diagmed Healthcare Ltd. Recent Developments/Updates
6.7 Q3 Medical Group
6.6.1 Q3 Medical Group Corporation Information
6.6.2 Q3 Medical Group Description and Business Overview
6.6.3 Q3 Medical Group Biliary and Pancreatic Stents Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Q3 Medical Group Biliary and Pancreatic Stents Product Portfolio
6.7.5 Q3 Medical Group Recent Developments/Updates
6.8 Hobbs Medical
6.8.1 Hobbs Medical Corporation Information
6.8.2 Hobbs Medical Description and Business Overview
6.8.3 Hobbs Medical Biliary and Pancreatic Stents Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Hobbs Medical Biliary and Pancreatic Stents Product Portfolio
6.8.5 Hobbs Medical Recent Developments/Updates
6.9 ACE Medical
6.9.1 ACE Medical Corporation Information
6.9.2 ACE Medical Description and Business Overview
6.9.3 ACE Medical Biliary and Pancreatic Stents Sales, Revenue and Gross Margin (2018-2023)
6.9.4 ACE Medical Biliary and Pancreatic Stents Product Portfolio
6.9.5 ACE Medical Recent Developments/Updates
6.10 Neuromedex
6.10.1 Neuromedex Corporation Information
6.10.2 Neuromedex Description and Business Overview
6.10.3 Neuromedex Biliary and Pancreatic Stents Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Neuromedex Biliary and Pancreatic Stents Product Portfolio
6.10.5 Neuromedex Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Biliary and Pancreatic Stents Industry Chain Analysis
7.2 Biliary and Pancreatic Stents Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Biliary and Pancreatic Stents Production Mode & Process
7.4 Biliary and Pancreatic Stents Sales and Marketing
7.4.1 Biliary and Pancreatic Stents Sales Channels
7.4.2 Biliary and Pancreatic Stents Distributors
7.5 Biliary and Pancreatic Stents Customers
8 Biliary and Pancreatic Stents Market Dynamics
8.1 Biliary and Pancreatic Stents Industry Trends
8.2 Biliary and Pancreatic Stents Market Drivers
8.3 Biliary and Pancreatic Stents Market Challenges
8.4 Biliary and Pancreatic Stents Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Published By : QY Research

Why ‘The Market Reports’